Baxter International Inc (BAX): EBITDA
$673.00M
Year ended 2025-12-31
$679.00M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $673.00M | -33.4% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $1.01B | -40.2% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $1.69B | n/m | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | -$1.77B | n/c | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $2.22B | n/c | 2024-02-08, From 2021-01-01 |
| 2020-12-31 | $2.44B | -4.8% | 2023-02-09, From 2020-01-01 |
| 2019-12-31 | $2.56B | +8.7% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $2.35B | +15.6% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $2.04B | n/c | 2020-03-17, From 2017-01-01 |
| 2016-12-31 | $1.54B | n/c | 2019-02-21, From 2016-01-01 |
| 2015-12-31 | $1.21B | -16.6% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $1.45B | +28.0% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $1.13B | n/a | 2016-02-26, From 2013-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Baxter International Inc (BAX) | 2025-12-31 | $673.00M | -33.4% |
| Solventum Corp (SOLV) | 2025-12-31 | $2.67B | +67.8% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $4.98B | +28.6% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $5.04B | +7.6% |
| ResMed Inc (RMD) | 2026-06-30 | $2.09B | +10.8% |
| 3M Co (MMM) | 2025-12-31 | $5.94B | -4.0% |
| Stryker Corp (SYK) | 2025-12-31 | $6.46B | +26.3% |
| Dexcom Inc (DXCM) | 2025-12-31 | $1.16B | +42.3% |
| Medline Inc. (MDLN) | 2025-12-31 | $3.22B | +3.2% |
Compare BAX, SOLV, BSX, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗